Oral Semaglutide
OASIS 2
Novo Nordisk · Phase 3 · Completed · Enrollment 201
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| oral semaglutide 50 mg once daily | Obesity or overweight | 50 mg | 68 | ITT | n/r |
| oral semaglutide placebo once daily | Obesity or overweight | n/r | 68 | ITT | n/r |